DrugDashboards

Drug recalls

FDA enforcement reports from the last 60 months · Class I is the most serious. Type in the filter box to search, click a column to sort, or toggle whether bulk API / for-further-processing products are included.

ⓘ How this was built
Data sources
  • openFDA drug enforcement reports (FDA)
Method

Rows are FDA's own enforcement records, ingested daily; classifications and dates are FDA's. Filtering and counting only — no modeling.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

All classesClass I (352)Class II (4,025)Class III (387)·1y2y5y
III—
D-0740-2026
Central Admixture Pharmacy Services IncIncorrect Product FormulationJul 16, 2026Ongoing
IIID-0737-2026
D-0737-2026
Ascend Laboratories, LLCFailed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12…Jul 16, 2026Ongoing
IIID-0739-2026
D-0739-2026
Ascend Laboratories, LLCFailed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12…Jul 16, 2026Ongoing
IIID-0738-2026
D-0738-2026
Ascend Laboratories, LLCFailed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12…Jul 16, 2026Ongoing
IIILidolog Kit
D-0713-2026
Asclemed USA Inc.Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scanJul 15, 2026Ongoing
IIID-0758-2026
D-0758-2026
Supernus Pharmaceuticals, Inc.Failed Dissolution SpecificationsJul 6, 2026Ongoing
IIID-0735-2026
D-0735-2026
Ascend Laboratories, LLCFailed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and T…Jun 30, 2026Ongoing
IIID-0736-2026
D-0736-2026
Ascend Laboratories, LLCFailed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and T…Jun 30, 2026Ongoing
IIIPrimidone
D-0585-2026
Amneal Pharmaceuticals, LLCCross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.Jun 3, 2026Ongoing
IIIHydroxyzine Hydrochloride
D-0619-2026
ANI Pharmaceuticals, Inc.Presence of foreign substanceJun 2, 2026Ongoing
III—
D-0654-2026
SUN PHARMACEUTICAL INDUSTRIES INCFailed Impurities/Degradation SpecificationsJun 1, 2026Ongoing
IIIFocalin XR
D-0608-2026
Sandoz IncLabeling: Incorrect or Missing Lot and/or Exp DateJun 1, 2026Ongoing
IIILidolog Kit
D-0552-2026
Eugia US LLCLabeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scanMay 18, 2026Ongoing
IIIPred Mild
D-0551-2026
AbbVie Inc.Failed Stability SpecificationsMay 18, 2026Ongoing
IIID-0581-2026
D-0581-2026
Fresenius Kabi USA, LLCFailed Impurities/Degradations SpecificationsMay 14, 2026Ongoing
IIINicotine
D-0550-2026
AVEVA Drug Delivery Systems, Inc.Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of i…May 14, 2026Ongoing
IIIBusulfan
D-0539-2026
Sagent PharmaceuticalsFailed Impurities/Degradation SpecificationsMay 4, 2026Ongoing
IIID-0537-2026
D-0537-2026
Amerisource Health Services LLCCross contamination with other products: API contaminated with trace amounts of Acemetacin API.May 1, 2026Ongoing
IIID-0536-2026
D-0536-2026
Amerisource Health Services LLCCross contamination with other products: API contaminated with trace amounts of Acemetacin API.May 1, 2026Ongoing
IIIPrimidone
D-0534-2026
Golden State Medical Supply Inc.Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.Apr 27, 2026Ongoing

Source: FDA drug enforcement reports (openFDA) · showing 20 of 386 recalls